Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 5 results found. Search for [ BNT162b2 ]

Results 1 to 5 of 5
BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 16, 2020
Pfizer and BioNTech's vaccine candidate, BNT162b2, is currently being evaluated in a global Phase 3 study ongoing at more than 120 clinical sites worldwide including the United States, Brazil, South Africa and Argentina


Reuters
September 8, 2020
Germany's vaccines regulator, the Paul Ehrlich Institute, gave the approval for the Phase 2/3 trial of the experimental vaccine known as BNT162b2, BioNTech and its partner Pfizer said in a statement


BusinessToday.In
July 15, 2020
Coronavirus vaccine news update: Moderna has said that its experimental COVID-19 vaccine has shown that it is safe and provokes immune responses in all 45 health volunteers in an early-stage study


BusinessToday.In
July 14, 2020
The World Health Organisation has stated that it won't be prudent to expect a perfect vaccine just yet. The warning comes on the back of a study by King's College, London that showed antibodies fighting COVID-19 in recovered patients began to wane away in three months


PAGES 1 OF 1